Projects of affiliated persons per year
Personal profile
Fingerprint
Dive into the research topics where Walter Jäger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Die Bedeutung einer intrakrinen Östrogenwirkung auf hormonabhängigen Erkrankungen
Jäger, W. (Project Lead)
1/07/17 → 30/06/20
Project: Research funding
-
-
-
Insights into interspecies protein binding variability using clindamycin as an example
Ahmed, H., Böhmdorfer, M., Jäger, W. & Zeitlinger, M. (Corresponding author), Feb 2025, In: Journal of Antimicrobial Chemotherapy. 80, 2, p. 363-371 9 p.Publications: Contribution to journal › Article › Peer Reviewed
Open Access -
Virucidal Potential of 3,3',4,4',5,5'-Hexahydroxy- trans-Stilbene Against Respiratory Syncytial Virus.
Bánki, Z., Wolf, L., Müllauer, B., Geisler-Moroder, D., Borena, W., Jäger, W. & Szekeres, T. (Corresponding author), 23 Sept 2025, In: Viruses. 17, 10, 1287.Publications: Contribution to journal › Article › Peer Reviewed
Open Access -
Antimicrobial Drug Penetration Is Enhanced by Lung Tissue Inflammation and Injury
Geilen, J., Kainz, M., Zapletal, B., Naka, A., Tichy, J., Jäger, W., Böhmdorfer, M., Zeitlinger, M., Schultz, M. J., Stamm, T., Ritschl, V., Geleff, S. & Tschernko, E., 1 Apr 2024, In: American Journal of Respiratory and Critical Care Medicine. 209, 7, p. 829-839 11 p.Publications: Contribution to journal › Article › Peer Reviewed
-
Assessment of drug induced proteome alterations exemplified on four breast cancer cell lines treated with the resveratrol derivative 3,3,4,4,5,5-hexahydroxystilbene
Kreutz, D. (Contributor), Bileck, A. (Contributor), Jäger, W. (Contributor) & Gerner, C. (Contributor)
20 Jul 2015Activity: Talks and presentations › Poster presentation › Science to Science
-
Stable isotope resolved metabolomics of erlotinib and gefitinib resistant non small-cell lung cancer (NSCLC) cell lines
Mader, R. M. (Contributor), Joerger, M. (Contributor), Vychalkovskiy, A. (Contributor) & Jäger, W. (Contributor)
21 Oct 2014Activity: Talks and presentations › Poster presentation › Science to Science
-
Stable isotope resolved metabolomics of erlotinib and gefitinib resistant non small-cell lung cancer (NSCLC) cell lines
Jäger, W. (Speaker)
20 Oct 2014Activity: Talks and presentations › Talk or oral contribution › Other